Showing 5471-5480 of 5771 results for "".
- Positive PEACHTREE Data to be Highlighted at Euretina 2018https://modernod.com/news/positive-peachtree-data-to-be-highlighted-at-euretina-2018/2479871/Clearside Biomedical announced that data from PEACHTREE, its pivotal phase 3 trial of suprachoroidal CLS-TA in patients with macular edema associated with non-infectious uveitis, will be presented by Ron Neumann, MD, Uveitis Specialist at Maccabi Health Services, Tel Aviv, Israel and co-Chair of
- Neurolens Appoints Thomas J. Chirillo as Chief Commercial Officerhttps://modernod.com/news/neurolens-appoints-thomas-j-chirillo-as-chief-commercial-officer/2479876/Neurolens announced the appointment of Thomas J. Chirillo as Chief Commercial Officer. An accomplished senior healthcare executive with deep experience in the eye care space, Mr. Chirillo brings almost 4 decades of sales and marketing experience to neurolens. “We’re thrilled to have someon
- FDA Grants Lin BioScience Rare Pediatric Disease Status for LBS-008 to Treat Stargardt Diseasehttps://modernod.com/news/fda-grants-lin-bioscience-rare-pediatric-disease-status-for-lbs-008-to-treat-stargardt-disease/2479877/Lin BioScience announced that the FDA has granted rare pediatric disease (RPD) designation to LBS-008, a first-in-class oral therapy for the treatment of Stargardt Disease. The Priority Review Voucher Program is intended to encourage development of therapies to prevent and treat rare pedi
- Heidelberg Engineering OCT Angiography Module Now Available in the United Stateshttps://modernod.com/news/heidelberg-engineering-oct-angiography-module-now-available-in-the-united-states/2479879/Heidelberg Engineering announced that it has received FDA clearance for its OCT Angiography Module (OCTA). The additional module is now available for new and existing Spectralis upgradeable diagnostic imaging devices.
- Oxurion to Present Scientific Findings Supporting Therapeutic Potential of THR-317 and THR-687 at EURETINAhttps://modernod.com/news/oxurion-to-present-scientific-findings-supporting-therapeutic-potential-of-thr-317-and-thr-687-at-euretina/2479880/Oxurion announced that it will give two presentations at the Euretina International Congress, which is being held in Vienna, Austria, from September 20-23, 2018. The presentation “Anti-inflammatory effects of the PlGF neutralizing antibody THR-317 in patients with diabetic macular edema” w
- Diopsys Highlights Educational Initiatives For ESCRS 2018https://modernod.com/news/diopsys-highlights-educational-initiatives-for-escrs-2018/2479883/Diopsys announced educational initiatives for the ESCRS 2018 Congress in Vienna, Austria, September 22-26. In addition to presentations that highlight how the various forms of testing available on Diopsys devices add to the management of eye care patients, the company will also be introducing the
- Quantel Medical Launches ABSolu Ultrasound Platformhttps://modernod.com/news/quantel-medical-launches-absolu-ultrasound-platform/2479884/Quantel Medical announced it will launch the ABSolu ultrasound platform at the ESCRS meeting in Vienna. Combining leading-edge technologies, the A/B/S/UBM ultrasound platform provides image quality with an exceptional
- Sun Pharma Receives FDA Approval for Xelpros to Treat Open-Angle Glaucoma or Ocular Hypertensionhttps://modernod.com/news/sun-pharma-and-sparc-announced-fda-approval-of-xelpros-to-treat-open-angle-glaucoma-or-ocular-hypertension/2479886/Sun Pharmaceutical Industries announced FDA approval of Xelpros (latanoprost ophthalmic emulsion 0.005%) for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension. Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium
- LumiThera to Debut Valeda Light Delivery System at EURETINAhttps://modernod.com/news/lumithera-to-debut-valeda-light-delivery-system-at-euretina/2479887/LumiThera announced that it will debut the Valeda Light Delivery System for the treatment of dry AMD in the exhibition hall at the EURETINA meeting in Vienna. It will also host a symposium on photobiomodulation (PBM) technology entitled, “Photobiomodulation: An Innovative, Mitochondria-targ
- Ziemer to Implement Low Energy Lenticule Extraction Applications for its Femtosecond Laser Platformhttps://modernod.com/news/ziemer-announces-to-implement-low-energy-lenticule-extraction-applications-to-its-femtosecond-laser-platform/2479888/Ziemer Ophthalmic Systems announced plans to incorporate lenticule extraction capabilities for its flagship LDV Z8 femtosecond laser system.1 “From the very first days of developing the femtosecond l